Risk factors for tumor upstaging in invasive melanoma include age, gender, race, tumor location, tumor size, pathologic stage, and biopsy method. Shortfalls in clinical management may explain why ...

This non-invasive monitoring tool ultimately helps improve patient prognosis. Overcoming a Key Challenge in Cancer Monitoring Minimal residual disease remains a critical challenge in cancer care: Even ...

This is considered an early form of cancer, a stage zero, that isn’t yet invasive. An Overview of Ductal Carcinoma In Situ (DCIS) Invasive Ductal Carcinoma Invasive ductal carcinoma (IDC), which is ...

For around one in four patients, however, the cells will eventually transform into invasive breast cancer. The diagnosis therefore challenges the textbook definition of cancer, and it can ...

NEW YORK – Scientists are working to better understand the role of germline pathogenic variants in the development of ductal carcinoma in situ (DCIS) and whether germline variants influence which ...

1Department of Medical Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York. *Corresponding Author: Jesus D. Anampa, Montefiore Einstein Comprehensive Cancer Center, 1695 ...

Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of recurrence and death.

Last month, a new randomised trial, published in JAMA once again, challenged the necessity of surgery for DCIS. Women with low-risk DCIS randomized to active monitoring did not have a higher rate of ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

The surgery, the first of its kind ever conducted in the UK, is intended to be a less invasive treatment for certain tumors located at the base of the skull. Kaviya was able to go home from the ...